REPORTED CASH FLOW STATEMENT Cash flow statement (unaudited) (€mm) Q3’15 Q3’14 Net cash provided by/(used in) operating activities 52.8 59.4 Net cash provided by/(used in) investing activities (4.5) (7.1) o/w capital expenditures (4.5) (2.1) Net cash provided by/(used in) financing activities (13.3) (0.8) Net increase/(decrease) in cash and cash equivalents 35.0 51.5 Cash and cash equivalents – beginning of period 128.4 186.5 Cash and cash equivalents – end of period 160.0 238.0
Operating cash-flow - Higher profit before tax - Negative impact of the decrease in working capital (-€9.3 million vs +€22.9 million in Q3 2014), mainly due to the accelerated payment process anticipating the ERP implementation
Investing cash flow - Capital expenditure of €4.5 million over the period related to the new DR site close to Paris
Financing cash flow - Consisting mainly in the €12.6 million spent for the acquisition of our own shares (1st tranche)
Significant cash outflow for tax payment expected in Q4 2015 due to the reconciliation between provisional payments from Q1 to Q3 and estimated taxable income for the current year (in France). 16